Sept 25 (Reuters) - Endo International PLC ENDP.O :
* ENDO ANNOUNCES FILL-FINISH MANUFACTURING AND SERVICES AGREEMENT FOR NOVAVAX COVID-19 VACCINE CANDIDATE
* ENDO INTERNATIONAL PLC - FINANCIAL AND OTHER TERMS OF AGREEMENT WERE NOT DISCLOSED.
* ENDO INTERNATIONAL PLC - PAR STERILE'S ROCHESTER FACILITY HAS BEGUN PRODUCTION OF NVX-COV2373 FINAL DRUG PRODUCT
* ENDO INTERNATIONAL PLC - INTERIM DATA FOR TRIALS IS EXPECTED BEFORE END OF 2020
* ENDO INTERNATIONAL PLC - PAR STERILE WILL ALSO FILL-FINISH NVX-COV2373 VACCINE INTENDED FOR COMMERCIAL DISTRIBUTION IN UNITED STATES.